Bumper Offer - Urjas oil Just @ Rs. 1
Monlevo, a prescription drug, is manufactured in various forms such as Tablet. Other than this, Monlevo has some other therapeutic uses, which have been discussed ahead.
The right dosage of Monlevo depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Monlevo include Headache, Stomach ache, Joint pain. Such side effects of Monlevo normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Monlevo is Severe for pregnant women and Severe for women who are breastfeeding. In addition, Monlevo's effects on the liver, heart and kidney are discussed below in the Monlevo related warnings section.
Monlevo is contraindicated in people with pre-existing medical conditions like Liver Disease as it can result in adverse effects.
Besides this, Monlevo may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Monlevo is considered not safe while driving, and is not addictive.
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Monlevo is used -
Common
Is the use of Monlevo safe for pregnant women?
Monlevo can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Monlevo safe during breastfeeding?
Taking Monlevo may lead to serious side effects if you are breastfeeding. Monlevo should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Monlevo on the Kidneys?
In the absence of any research, there are no known side effects of Monlevo on kidneys.
What is the effect of Monlevo on the Liver?
So far, no research has been carried out on the effects of Monlevo on the liver. So it is not known whether taking Monlevo will affect the liver or not.
What is the effect of Monlevo on the Heart?
There is no research available on the side effects of Monlevo on the heart. Therefore, its impact is unknown.
Monlevo should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Monlevo unless your doctor advises you to do so -
Is this Monlevo habit forming or addictive?
No, there is no any evidence that Monlevo is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Monlevo you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Monlevo should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Monlevo is not used to treat mental disorders.
Interaction between Food and Monlevo
Due to the absence of research, it is difficult to say how Monlevo and food will interact.
Interaction between Alcohol and Monlevo
No research has been done on this till date. Therefore, it is not known what the effect of taking Monlevo with alcohol will be.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xyzal® (levocetirizine dihydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,167
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)
Product Index [Internet]: MONTAIR LC & MONTAIR LC KID DT / Syrup (Montelukast sodium + Levocetirizine dihydrochloride ). Ciplamed
Highlights of Prescribing Information [Internet]: XYZAL® (levocetirizine dihydrochloride) tablets . Initial U.S. Approval: 19952007
Smpc [Internet]: montelukast sodium. Aurobindo Pharma
Package leaflet Information for the patient [Internet]: Xyzal 0.5 mg/ml oral solution. UCB Pharma Ltd
